Eligibility Obesity NCT00708266

  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT00708266
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent signed before any study activities.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
age of 18 years old or above.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
a body mass index (bmi) within the limits of 18.5 to 24.9 (normal range).
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
any clinical signs of acute or chronic inflammation detectable during study visit 1.
Beschreibung

Signs Inflammation | Signs Chronic inflammation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0311392
UMLS CUI [1,2]
C0021368
UMLS CUI [2,1]
C0311392
UMLS CUI [2,2]
C0021376
severe acute or chronic diseases (e.g. acute respiratory tract infection, systemic lupus erythematosus, rheumatoid arthritis).
Beschreibung

Disease Severe | Chronic disease Severe | Respiratory Tract Infection | Lupus Erythematosus, Systemic | Rheumatoid Arthritis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0008679
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0035243
UMLS CUI [4]
C0024141
UMLS CUI [5]
C0003873
mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
Beschreibung

Mental handicap Excludes Comprehension | Mental handicap Excludes Cooperation | Comprehension Unwilling | Cooperation Unwilling | Language Barriers Exclude Comprehension | Language Barriers Exclude Cooperation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1306341
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0162340
UMLS CUI [2,1]
C1306341
UMLS CUI [2,2]
C0332196
UMLS CUI [2,3]
C0392337
UMLS CUI [3,1]
C0162340
UMLS CUI [3,2]
C0558080
UMLS CUI [4,1]
C0392337
UMLS CUI [4,2]
C0558080
UMLS CUI [5,1]
C0237167
UMLS CUI [5,2]
C0332196
UMLS CUI [5,3]
C0162340
UMLS CUI [6,1]
C0237167
UMLS CUI [6,2]
C0332196
UMLS CUI [6,3]
C0392337
use of any vasoactive substances (e.g. anti-hypertensive drugs), immune-suppressant or anti-inflammatory drugs (e.g. corticosteroids, aspirin, other cox2 inhibitors) or anti-coagulation treatment.
Beschreibung

Vasoactive agent | Antihypertensive Agents | Immunosuppressive Agents | Anti-Inflammatory Agents | Adrenal Cortex Hormones | Aspirin | Cyclooxygenase 2 Inhibitors | Anticoagulation Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0597639
UMLS CUI [2]
C0003364
UMLS CUI [3]
C0021081
UMLS CUI [4]
C0003209
UMLS CUI [5]
C0001617
UMLS CUI [6]
C0004057
UMLS CUI [7]
C1257954
UMLS CUI [8]
C0003281
diseases of the skin which could interfere with catheter insertion in the abdominal wall.
Beschreibung

Dermatologic disorder Interferes with Catheter insertion Abdominal wall

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0037274
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0007430
UMLS CUI [1,4]
C0836916
pregnancy in women subjects.
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961

Ähnliche Modelle

Eligibility Obesity NCT00708266

  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT00708266
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
informed consent signed before any study activities.
boolean
C0021430 (UMLS CUI [1])
Age
Item
age of 18 years old or above.
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
a body mass index (bmi) within the limits of 18.5 to 24.9 (normal range).
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Signs Inflammation | Signs Chronic inflammation
Item
any clinical signs of acute or chronic inflammation detectable during study visit 1.
boolean
C0311392 (UMLS CUI [1,1])
C0021368 (UMLS CUI [1,2])
C0311392 (UMLS CUI [2,1])
C0021376 (UMLS CUI [2,2])
Disease Severe | Chronic disease Severe | Respiratory Tract Infection | Lupus Erythematosus, Systemic | Rheumatoid Arthritis
Item
severe acute or chronic diseases (e.g. acute respiratory tract infection, systemic lupus erythematosus, rheumatoid arthritis).
boolean
C0012634 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0008679 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0035243 (UMLS CUI [3])
C0024141 (UMLS CUI [4])
C0003873 (UMLS CUI [5])
Mental handicap Excludes Comprehension | Mental handicap Excludes Cooperation | Comprehension Unwilling | Cooperation Unwilling | Language Barriers Exclude Comprehension | Language Barriers Exclude Cooperation
Item
mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
boolean
C1306341 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C1306341 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0392337 (UMLS CUI [2,3])
C0162340 (UMLS CUI [3,1])
C0558080 (UMLS CUI [3,2])
C0392337 (UMLS CUI [4,1])
C0558080 (UMLS CUI [4,2])
C0237167 (UMLS CUI [5,1])
C0332196 (UMLS CUI [5,2])
C0162340 (UMLS CUI [5,3])
C0237167 (UMLS CUI [6,1])
C0332196 (UMLS CUI [6,2])
C0392337 (UMLS CUI [6,3])
Vasoactive agent | Antihypertensive Agents | Immunosuppressive Agents | Anti-Inflammatory Agents | Adrenal Cortex Hormones | Aspirin | Cyclooxygenase 2 Inhibitors | Anticoagulation Therapy
Item
use of any vasoactive substances (e.g. anti-hypertensive drugs), immune-suppressant or anti-inflammatory drugs (e.g. corticosteroids, aspirin, other cox2 inhibitors) or anti-coagulation treatment.
boolean
C0597639 (UMLS CUI [1])
C0003364 (UMLS CUI [2])
C0021081 (UMLS CUI [3])
C0003209 (UMLS CUI [4])
C0001617 (UMLS CUI [5])
C0004057 (UMLS CUI [6])
C1257954 (UMLS CUI [7])
C0003281 (UMLS CUI [8])
Dermatologic disorder Interferes with Catheter insertion Abdominal wall
Item
diseases of the skin which could interfere with catheter insertion in the abdominal wall.
boolean
C0037274 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0007430 (UMLS CUI [1,3])
C0836916 (UMLS CUI [1,4])
Pregnancy
Item
pregnancy in women subjects.
boolean
C0032961 (UMLS CUI [1])